COMBINATION OF OZOGAMICIN INOTUZUMAB AND TORIZEL FOR TREATING CANCER Russian patent published in 2017 - IPC A61K39/395 A61K31/436 A61P35/00

Abstract RU 2607594 C2

FIELD: medicine.

SUBSTANCE: invention relates to therapeutic method of treating cancer, which is non-Hodgkin’s lymphoma; method involves stage of introducing simultaneously or successively effective number of ozogamicin inotuzumab (SMS-544) in dose of 0.4 mg/m² up to 1.8 mg/m² every 4 weeks throughout 6 cycles and temsirolimus in dose of 5 to 175 mg/week during disease progression.

EFFECT: invention provides low toxicity, associated with treatment using ozogamicin inotuzumab or temsirolimus.

7 cl, 8 ex, 11 tbl

Similar patents RU2607594C2

Title	Year	Author	Number
PHARMACEUTICAL COMPOSITION AND METHODS OF TREATING CANCER AND ITS METASTASES	2006	Rejdmejker Bernardus	RU2401662C2
COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID	2011	Moneo Okanja Viktorija Santamarija Nunes Khema Garsia Fernandes Luis Fransisko Galmarini Karlos Marija Gilen Navarro Marija Khose Aviles Marin Pablo Manuel	RU2605335C2
COMBINATION THERAPY WITH ANTITUMOR ALKALOID	2011	Moneo Ocana Victoria Santamaria Nunez Gema Garcia Fernandez Luis Francisco Galmarini Carlos Maria Guillen Navarro Maria Jose Aviles Marin Pablo Manuel	RU2743643C2
COMBINATION THERAPY WITH ANTICANCER ALKALOID	2018	Moneo Ocana, Victoria Santamaria Nunez, Gema Garcia Fernandez, Luis Francisco Galmarini, Carlos Maria Guillen Navarro, Maria Jose Aviles Marin, Pablo Manuel	RU2767664C2
COMBINATION THERAPY WITH ANTITUMOR ALKALOID	2018	Moneo Ocana, Victoria Santamaria Nunez, Gema Garcia Fernandez, Luis Francisco Galmarini, Carlos Maria Guillen Navarro, Maria Jose Aviles Marin, Pablo Manuel	RU2757373C2
METHODS OF TREATING CANCER USING APILIMOD	2016	Likhenshtejn Khenri Rotberg Dzhonatan M. Gejl Sofiya Bikharri Nil Bekett Pol Landrette Shon Konrad Kris Syuj Tyan	RU2738934C2
INTERMEDIATE CHEMICAL COMPOUNDS AND METHODS FOR PRODUCING COMPOUNDS	2013	Khan Chun	RU2635359C2
COMBINED CHEMOTHERAPY	2001	Smit Mark Pirt Stefens Trevor Charl'Z	RU2284818C2
COMBINED CHEMOTHERAPY	2006	Smit Mark Pirt Stefens Trevor Charl'Z	RU2429838C2
COMBINATION THERAPY WITH NON-FUCOSYLATED ANTI-CD20 ANTIBODY AND BENDAMUSTINE	2010	Frank Kherting Kristian Klajn	RU2575820C2

RU 2 607 594 C2

Authors

Bruederle Andreas

Moran Pedreig

Statkhis Anastasios

Dates

2017-01-10—Published

2012-12-04—Filed